96 13F filers hold it · −8 against the quarter before · shares held −9.0%
Holdings of 06/30
StocksIs Wall Street adding or cutting?−8 Who bought more than 5%?6.7%
All tracked funds
All 5% stake reports on Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Health care sectorNasdaq
What to see in Black Diamond Therapeutics now
BlackRock holds 6.7% · +2.2pp on the report before
Filed 07/27
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, Massachusetts
- Fiscal year end
- 12/31
- Next earnings
- 10/31, estimated
- 96 13F filers hold it · −8 against the quarter before · shares held −9.0%Holdings of 06/30
- BlackRock holds 6.7% · +2.2pp on the report beforeFiled 07/27
Funds
13F filers: 96 · −8 since the quarter before · 06/30 holdings
Famous funds that held Black Diamond Therapeutics in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsBlack Diamond Therapeutics BDTX · 06/30 holdings | $40.2K | No quarter before |
| Mirae Asset Global InvestmentsBlack Diamond Therapeutics BDTX · 06/30 holdings | $4,742 | Trimmed −13.8% |
5% stakes
| Holder | ||
|---|---|---|
| BlackRock07/27 | 6.7%3,838,590 sh | +2.2pp |
| BB Biotech25/03/21 | 4.8%2,733,547 sh | −10.3pp |